Curious what ChatGPT could offer the rare disease community, columnist Candace Semien used the AI tool to prepare for a ...

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

Columnist Marisa Zeppieri welcomes the season of holiday food while offering tips to get people with lupus through any ...